Skip to content

STAES - VAN CAMP

Active
Private limited companyfounded 201511 yrs activeHeidelaan 18, 2280 Grobbendonk, BelgiumKBO/BCE: BE 0636.788.271

STAES - VAN CAMP has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €384k and a net result of €39k. Equity is growing by ~10% per year across the filed fiscal years. Its solvency ranks better than 69% of 10345 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.1% (low).

Checked score

Score 2025
65 / 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability43▼-28
Solvency82▼-15
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
1.1% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €24k at 30 days acceptable
Liquidity ample (current ratio 2.03 against 2.6 in 2024; short-term debt: 43.2% and cash: 30.1% of total assets), and 43.2% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
56.8%
Return on assets
5.8%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-06-2026, 49 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
49 d early
2024
7 d early
2023
20 d early
2022
24 d early
2021
27 d early
2020
18 d early
2019
30 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Equity
€384k▼ 13.9%
2024 · €446k
2018: €164k 2019: €242k 2020: €341k 2021: €391k 2022: €444k 2023: €451k 2024: €446k
2018 → 2025
Total assets
€677k▲ 8.5%
2024 · €624k
2018: €987k 2019: €836k 2020: €760k 2021: €833k 2022: €721k 2023: €757k 2024: €624k
2018 → 2025
Net result
€39k▼ 63.5%
2024 · €107k
2018: €76k 2019: €81k 2020: €101k 2021: €79k 2022: €79k 2023: €85k 2024: €107k
2018 → 2025
Working capital
€301k▲ 6.0%
2024 · €284k
2018: €132k 2019: €178k 2020: €273k 2021: €307k 2022: €323k 2023: €223k 2024: €284k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€391k-€444k▲ 13.6%€451k▲ 1.7%€446k▼ 1.1%€384k▼ 13.9%
Operating result€210k-€224k▲ 6.8%€210k▼ 6.2%€248k▲ 17.7%€187k▼ 24.5%
Net result€79k-€79k▲ 1.1%€85k▲ 6.5%€107k▲ 26.7%€39k▼ 63.5%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100k€200kOperating result 2021: €210k€210kNet result 2021: €79k€79kOperating result 2022: €224k€224kNet result 2022: €79k€79kOperating result 2023: €210k€210kNet result 2023: €85k€85kOperating result 2024: €248k€248kNet result 2024: €107k€107kOperating result 2025: €187k€187kNet result 2025: €39k€39k20212022202320242025
The operating result falls in 2025; 2025 is 24% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €677k
Fixed assets €83k▼ 48.8%
Current assets €594k▲ 28.7%
Equity and liabilities €677k
Equity €384k▼ 13.9%
Debt €293k▲ 65.1%
The debt ratio rises from 28.4% to 43.2%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€271k
2024 · €337k
Cash flow
€123k
2024 · €196k
Solvency
56.8%
2024 · 71.6%
Current ratio
2.03
2024 · 2.60
Quick ratio
1.50
2024 · 1.84
Debt / equity
0.76
2024 · 0.40
ROE
10.2%
2024 · 24.0%
ROA
5.8%
2024 · 17.2%
Interest coverage
2.09
2024 · 3.63
Debt
€293k
2024 · €177k
Debt ≤ 1 year
€293k
2024 · €177k
Income taxes
€18k
2024 · €48k
Staff costs
€75k
2024 · €53k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€624k€677k
Fixed assets21/28€162k€83k
Intangible fixed assets21€56k-
Tangible fixed assets22/27€106k€83k
Plant, machinery and equipment23€23k€24k
Furniture and vehicles24€83k€59k
Current assets29/58€461k€594k
Stocks and contracts in progress3€135k€155k
Stocks30/36€135k€155k
Amounts receivable within one year40/41€170k€210k
Trade receivables40€169k€197k
Other amounts receivable41€839€13k
Cash at bank and in hand54/58€156k€204k
Deferred charges and accrued income490/1€404€25k
Equity and liabilities
Total equity and liabilities10/49€624k€677k
Equity10/15€446k€384k
Reserves13€446k€384k
Non-distributable reserves130/1€3k€3k=
Reserves not available under the articles1311€3k€3k=
Distributable reserves133€443k€381k
Amounts payable17/49€177k€293k
Amounts payable within one year42/48€177k€293k
Current portion of amounts payable after more than one year42€15k-
Trade debts44€50k€167k
Suppliers440/4€50k€167k
Taxes, remuneration and social security45€36k€29k
Taxes450/3€29k€18k
Remuneration and social security454/9€8k€11k
Other amounts payable47/48€76k€96k
Income statement Code20242025
Remuneration, social security and pensions62€53k€75k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€89k€84k
Other operating charges640/8€432€568
Gross operating margin9900€390k€347k
Operating profit (loss)9901€248k€187k
Financial income75/76B€128€181
Recurring financial income75€128€181
Financial charges65/66B€93k€130k
Recurring financial charges65€93k€130k
Profit (loss) for the period before taxes9903€155k€57k
Income taxes67/77€48k€18k
Profit (loss) for the period9904€107k€39k
Profit (loss) for the period to be appropriated9905€107k€39k
Appropriation of the result
Profit (loss) to be appropriated9906€107k€39k
Transfer from equity791/2€78k€100k
Transfer to equity691/2€106k€38k
To other reserves6921€106k€38k
Profit to be distributed694/7€79k€101k
Return on contributions (dividend)694€79k€101k
Social balance
Average headcount (FTE)90870.90.9=

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
12-06
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial Weakest financial yearnet €39k ▼63.5%
Net result drops to €39k, the lowest in the series.
24-07
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial Highest result since 2018net €107k ▲26.7%
Operating result €248k, net result €107k, both a record.
11-07
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
07-07
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
04-07
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
13-07
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
01-07
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-12
Financial Equity above €200kEq €242k ▲47.5%
2 profitable years in a row build equity to €242k.
02-07
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
09-07
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
20-06
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Grobbendonk · 3 establishment units since 2015
establishment All 3 establishment units on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Heidelaan 182280 Grobbendonk
Ground area
2,109 m²
Building footprint
456 m²
Volume, LiDAR
2,704 m³
3 parcels, Flanders · tallest building 9.4 m, ±3 floors. Linked by address, not a title deed.
3 establishment units
Heidelaan 18, 2280 Grobbendonk
Retail sale of pharmaceutical products
since 20152.245.289.583
De Lindeboom apotheek
Guido Gezellestraat 14, 2530 BoechoutRetail sale of pharmaceutical products
since 20152.258.193.256
De Lindeboom apotheek Nijlen
Statiestraat 8, 2560 NijlenRetail sale of pharmaceutical products
since 20162.258.193.157
3 parcels
Flanders 3 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
13010C0049/00C007 Flanders 1,691 m² 1 · 211 m² 9.0 m · 2 fl.
11004A0172/00W000 Flanders 286 m² 1 · 134 m² 9.4 m · 3 fl.
12026D0412/00G005 Flanders 131 m² 1 · 111 m² 9.4 m · 3 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 2
3 of 3 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Public money · subsidies and aid

Flemish government

2024 · 1 entry · 2,000 EUR awarded · 2,000 EUR paid
Year Entries awardedpaid
2024 1 2,000 EUR2,000 EUR
Schemes
Hinderpremie bij openbare werken
1 entry · 2,000 EUR · 2,000 EUR paid · Fonds voor Innoveren en Ondernemen

Recognitions · licences · registrations

Food safety, FASFC

2 sites
Boechout2.258.193.256
1 permission
Apotheek (LM>3 maand) · since 10-08-2026
Nijlen2.258.193.157
1 permission
Apotheek (LM>3 maand) · since 10-08-2026

Legal Entity Identifier

254900Y8RLHU1BA2TI83
live in the LEI register

Similar companies · same sector, comparable size

Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 3,446 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded20-08-2015
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 10 filingsAddress and cadastre registers

Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.

Contact details

2 entries
E-mail:janstaes@zorgenfarma.be
Establishment Grobbendonk 2.245.289.583
Phone:0479388812
Establishment Grobbendonk 2.245.289.583